Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
D000535:Aluminum / Q000494:pharmacology; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D002087:Butyrates / Q000494:pharmacology*; D002784:Cholesterol / Q000378:metabolism; D002994:Clofibrate / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005951:Glucose Tolerance Test; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D009929:Organ Size; D010636:Phenols / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D014280:Triglycerides / Q000378:metabolism
D000924:Anticholesteremic Agents; D002087:Butyrates; D005230:Fatty Acids, Nonesterified; D000960:Hypolipidemic Agents; D008112:Liver Glycogen; D010636:Phenols; D010743:Phospholipids; D014280:Triglycerides; D002784:Cholesterol; D000535:Aluminum; D002994:Clofibrate